Francesco Paoloni

4PUBLICATIONS
67CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Aug 27, 2025
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.

Federica Pecci, Hui Li, Alessandro Di Federico

|Jul 24, 2025
Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Justin J Kim, Sara A Walton, Navin R Mahadevan

|Jul 24, 2023
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.

Alessandro Parisi, Francesca Rossi, Chiara De Filippis

Pageof 1